Free Trial

Structure Therapeutics (GPCR) SEC Filings & 10K Form

Structure Therapeutics logo
$31.00 -0.25 (-0.80%)
(As of 12/16/2024 ET)

Recent Structure Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
11/14/2024
9:26 AM
JANUS HENDERSON GROUP PLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G
11/14/2024
8:33 AM
Avoro Capital Advisors LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
11/13/2024
3:16 PM
Structure Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
9:34 AM
FMR LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
11/08/2024
9:52 AM
Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
09/20/2024
4:41 PM
Coll Crespo Blas (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
4:42 PM
Coll Crespo Blas (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
4:45 PM
Hall Ashley (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
4:47 PM
Hall Ashley (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:35 PM
Russell Angus C. (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2024
3:37 PM
Russell Angus C. (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:16 PM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:23 PM
Structure Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/27/2024
4:00 PM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:15 PM
Structure Therapeutics (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Structure Therapeutics (Issuer)
TETLOW SHARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
DOBMEIER ERIC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Structure Therapeutics (Issuer)
Waldstreicher Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
LOVE TED W (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
7:19 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:07 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2024
3:42 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:07 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
11:15 PM
Structure Therapeutics (Filer)
Form EFFECT
06/05/2024
6:38 PM
Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:43 PM
Structure Therapeutics (Filer)
Form S-1MEF
06/03/2024
7:00 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
5:57 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Structure Therapeutics (Subject)
Form SC 13G
05/09/2024
3:56 PM
Structure Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:10 PM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
4:24 PM
Structure Therapeutics (Filer)
Form ARS
04/19/2024
1:13 PM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
6:34 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:37 PM
Structure Therapeutics (Issuer)
Yoon Jun (Reporting)
Form 4/A
03/20/2024
6:39 PM
Ma Yingli (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:41 PM
Bach Mark Allen (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:42 PM
Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/19/2024
3:36 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:52 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:19 PM
Structure Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
AI breakthrough about to upend industry (Ad)

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

03/08/2024
8:19 AM
Structure Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2024
7:43 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
10:11 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:07 AM
Avoro Capital Advisors LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G
02/14/2024
7:45 AM
Deep Track Capital, LP (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/09/2024
6:59 AM
FIL Ltd (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/06/2024
10:01 AM
Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/27/2023
9:49 AM
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
9:49 AM
FMR LLC (Reporting)
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:36 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
12/18/2023
7:28 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GPCR) was last updated on 12/17/2024 by MarketBeat.com Staff
From Our Partners